SGIOY
Price
$8.41
Change
-$0.11 (-1.29%)
Updated
Apr 23 closing price
Capitalization
12.4B
18 days until earnings call
TAK
Price
$15.18
Change
-$0.15 (-0.98%)
Updated
Apr 23 closing price
Capitalization
43.11B
14 days until earnings call
Ad is loading...

SGIOY vs TAK

Header iconSGIOY vs TAK Comparison
Open Charts SGIOY vs TAKBanner chart's image
Shionogi & Co
Price$8.41
Change-$0.11 (-1.29%)
Volume$43.11K
Capitalization12.4B
Takeda Pharmaceutical
Price$15.18
Change-$0.15 (-0.98%)
Volume$1.6M
Capitalization43.11B
SGIOY vs TAK Comparison Chart
Loading...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOY vs. TAK commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOY is a StrongBuy and TAK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (SGIOY: $8.41 vs. TAK: $15.18)
Brand notoriety: SGIOY and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SGIOY: 54% vs. TAK: 84%
Market capitalization -- SGIOY: $12.4B vs. TAK: $43.11B
SGIOY [@Pharmaceuticals: Other] is valued at $12.4B. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOY’s FA Score shows that 2 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).

  • SGIOY’s FA Score: 2 green, 3 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, SGIOY is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOY’s TA Score shows that 4 TA indicator(s) are bullish while TAK’s TA Score has 8 bullish TA indicator(s).

  • SGIOY’s TA Score: 4 bullish, 4 bearish.
  • TAK’s TA Score: 8 bullish, 3 bearish.
According to our system of comparison, TAK is a better buy in the short-term than SGIOY.

Price Growth

SGIOY (@Pharmaceuticals: Other) experienced а +3.44% price change this week, while TAK (@Pharmaceuticals: Other) price change was +3.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.96%. For the same industry, the average monthly price growth was -6.07%, and the average quarterly price growth was -9.98%.

Reported Earning Dates

SGIOY is expected to report earnings on Aug 04, 2025.

TAK is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($43.1B) has a higher market cap than SGIOY($12.4B). TAK has higher P/E ratio than SGIOY: TAK (36.79) vs SGIOY (9.62). SGIOY YTD gains are higher at: 20.835 vs. TAK (14.653). TAK has higher annual earnings (EBITDA): 1.01T vs. SGIOY (242B). SGIOY has more cash in the bank: 563B vs. TAK (317B). SGIOY has less debt than TAK: SGIOY (9.41B) vs TAK (4.66T). TAK has higher revenues than SGIOY: TAK (4.17T) vs SGIOY (427B).
SGIOYTAKSGIOY / TAK
Capitalization12.4B43.1B29%
EBITDA242B1.01T24%
Gain YTD20.83514.653142%
P/E Ratio9.6236.7926%
Revenue427B4.17T10%
Total Cash563B317B178%
Total Debt9.41B4.66T0%
FUNDAMENTALS RATINGS
SGIOY vs TAK: Fundamental Ratings
SGIOY
TAK
OUTLOOK RATING
1..100
2618
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
7560
SMR RATING
1..100
178
PRICE GROWTH RATING
1..100
4043
P/E GROWTH RATING
1..100
6156
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (12) in the Pharmaceuticals Major industry is in the same range as SGIOY (28) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TAK's Profit vs Risk Rating (60) in the Pharmaceuticals Major industry is in the same range as SGIOY (75) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

SGIOY's SMR Rating (1) in the null industry is significantly better than the same rating for TAK (78) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew significantly faster than TAK’s over the last 12 months.

SGIOY's Price Growth Rating (40) in the null industry is in the same range as TAK (43) in the Pharmaceuticals Major industry. This means that SGIOY’s stock grew similarly to TAK’s over the last 12 months.

TAK's P/E Growth Rating (56) in the Pharmaceuticals Major industry is in the same range as SGIOY (61) in the null industry. This means that TAK’s stock grew similarly to SGIOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOYTAK
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
29%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
41%
MACD
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
47%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
42%
Advances
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
44%
Declines
ODDS (%)
Bearish Trend 14 days ago
59%
Bearish Trend 17 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
33%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
29%
View a ticker or compare two or three
Ad is loading...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VXTRF0.02N/A
+18.64%
VOXTUR ANALYTICS CORP.
NSNRX40.82N/A
N/A
Neuberger Berman Small Cap Growth R3
WILNX19.53N/A
N/A
William Blair International Ldrs N
HEOIX15.31N/A
N/A
Hartford Climate Opportunities I
TRWTX22.11N/A
N/A
Transamerica International Equity I3

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
-1.29%
TAK - SGIOY
40%
Loosely correlated
-0.98%
ESAIY - SGIOY
36%
Loosely correlated
-1.26%
KMDA - SGIOY
27%
Poorly correlated
+1.70%
SCYX - SGIOY
23%
Poorly correlated
+2.74%
SUPN - SGIOY
22%
Poorly correlated
-0.06%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with SGIOY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then SGIOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-0.98%
SGIOY - TAK
41%
Loosely correlated
-1.29%
ESAIY - TAK
35%
Loosely correlated
-1.26%
BNXTF - TAK
32%
Poorly correlated
+7.74%
HLN - TAK
31%
Poorly correlated
-2.11%
CPHI - TAK
28%
Poorly correlated
-4.91%
More